• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC UNKNOWN; INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC UNKNOWN; INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT, Back to Search Results
Model Number MSB_UNK_HARDWARE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Nerve Damage (1979)
Event Date 06/01/2023
Event Type  Injury  
Manufacturer Narrative
H6: neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.D4: product <(>&<)> lot# unknown g3: ¿pma / 510(k) #: unknown b3: literature published date medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Alexander o.Aguirre, mohamed a.R.Soliman, nicholas j.Minissale, patrick k.Jowdy, cathleen c.Kuo, asham khan, ryan m.Hess, david e.Smolar, barrett i.Woods, mark s.Eskander, paul j.Slosar, john pollina, jeffrey p.Mullin objective: interbody cages for spinal fusions are primarily constructed from polyetheretherketone or titanium compositions.However, these crude macroscopic materials pose limitations for improving the rates of bony fusions.The authors aimed to compare the fusion rates and postoperative complications in patients who underwent 2- level or 3-or 4-level anterior cervical discectomy and fusion (acdf) performed with the use of a novel biomimetic surface titanium cage.Methods: a retrospective multicenter study was conducted that included all patients who underwent multilevel acdf with this cage between january 2017 and april 2021.Patient demographics and procedure-related, radiographic, and postoperative complication data were collected.Results: a total of 124 patients were identified; 69 (55.6%) had a 3-or 4-level fusion and 55 (44.4%) had a 2- level fusion.The demographics of the 2 groups differed significantly only in terms of age (p [ 0.01).At 3 months, a significantly higher solid fusion rate was found for 2-level fusions than 3-or 4-level fusions (83.7% vs.56.3%, p [0.004); however, significance was lost at 6-months (98.2% vs.88.4%, respectively; p [ 0.08).No patients required posterior supplemental fixation.Transient dysphagia was the only postoperative complication that was significantly increased in the 3-or 4-level fusion group compared to the 2-level group (27.5% vs.9.1%, p [ 0.02).Reported events: the rate of postoperative dysphagia was significantly higher in the 3- or 4-level group than the 2-level group (27.5% vs.9.1%, p ¼ 0.02).There was no statistically significant difference found in the occurrence of other complications between the groups.Two (2.9%) infections were seen in the 3- or 4-level group; both were deep instrumentation infections that required surgical revision with instrumentation replacement and antibiotics; however, after surgical revision, both patients recovered with no additional complications.One (1.4%) other patient in the 3- or 4-level group had adjacent segment disease requiring an anterior extension of the fusion.One (1.8%) patient in the 2-level group required a second operation within 90 days from surgery to replace a migrated cage that caused cervical stenosis; after reoperation, this patient recovered with no additional complications.Conclusions: radiographic and clinical outcomes were equivalent in 3-or 4-level and 2-level acdfs in which these biomimetic surface titanium cages were used.Furthermore, the use of this technology led to high fusion rates with no requirement for posterior supplemental fusions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN
Type of Device
INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT,
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer Contact
glen belmer
1800 pyramid place
memphis, TN 38132
6122713209
MDR Report Key18950592
MDR Text Key338253785
Report Number1030489-2024-00195
Device Sequence Number1
Product Code MAX
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
UNKNOWN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/21/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberMSB_UNK_HARDWARE
Device Catalogue NumberMSB_UNK_HARDWARE
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/22/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-